Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan R Kirsch

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Science Translational Medicine|October 9, 2015
TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCLIlan R Kirsch, Rei Watanabe, John T O'Malley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 15, 2003
Distinguishing right from left colon by the pattern of gene expressionOleg K Glebov, Luz M Rodriguez, Kenneth Nakahara, et al.
Science Translational Medicine|May 11, 2018
High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoidesAdele de Masson, John T O'Malley, Christopher P Elco, et al.
Frontiers in Immunology|March 23, 2026
The genetic basis of the immune response to SARS-CoV-2 infection and vaccination in the Italian municipality of Vo'Ettore Zapparoli, Enrico Lavezzo, Hélène Tonnelé, et al.
Cancer Research|March 3, 2004
Genetics and cytogenetics of multiple myeloma: a workshop reportRafael Fonseca, Bart Barlogie, Regis Bataille, et al.
Eclinicalmedicine|July 3, 2023
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencingStefania Oliva, Elisa Genuardi, Laura Paris, et al.
BMC Cancer|July 2, 2020
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myelomaTravers Ching, Megan E Duncan, Tera Newman-Eerkes, et al.
Cancer Research|January 10, 2023
Challenges to Using Big Data in CancerShawn M Sweeney, Hisham K Hamadeh, Natalie Abrams, et al.
Cancer Research|January 10, 2023
Case Studies for Overcoming Challenges in Using Big Data in CancerShawn M Sweeney, Hisham K Hamadeh, Natalie Abrams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2017
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future ApplicationsKenneth C Anderson, Daniel Auclair, Gary J Kelloff, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Science Translational Medicine|October 9, 2015
TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCLIlan R Kirsch, Rei Watanabe, John T O'Malley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 15, 2003
Distinguishing right from left colon by the pattern of gene expressionOleg K Glebov, Luz M Rodriguez, Kenneth Nakahara, et al.
Science Translational Medicine|May 11, 2018
High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoidesAdele de Masson, John T O'Malley, Christopher P Elco, et al.
Frontiers in Immunology|March 23, 2026
The genetic basis of the immune response to SARS-CoV-2 infection and vaccination in the Italian municipality of Vo'Ettore Zapparoli, Enrico Lavezzo, Hélène Tonnelé, et al.
Cancer Research|March 3, 2004
Genetics and cytogenetics of multiple myeloma: a workshop reportRafael Fonseca, Bart Barlogie, Regis Bataille, et al.
Eclinicalmedicine|July 3, 2023
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencingStefania Oliva, Elisa Genuardi, Laura Paris, et al.
BMC Cancer|July 2, 2020
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myelomaTravers Ching, Megan E Duncan, Tera Newman-Eerkes, et al.
Cancer Research|January 10, 2023
Challenges to Using Big Data in CancerShawn M Sweeney, Hisham K Hamadeh, Natalie Abrams, et al.
Cancer Research|January 10, 2023
Case Studies for Overcoming Challenges in Using Big Data in CancerShawn M Sweeney, Hisham K Hamadeh, Natalie Abrams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2017
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future ApplicationsKenneth C Anderson, Daniel Auclair, Gary J Kelloff, et al.
Pageof 6